Key result
Non-vitamin K antagonist oral anticoagulants (NOACs) were superior or non-inferior to warfarin for stroke prevention in Asian patients with atrial fibrillation.
Why the study?
Do NOACs improve stroke prevention and reduce bleeding compared to warfarin in Asian patients with atrial fibrillation?
Population
Asian patients with atrial fibrillation
Comparison
Non-vitamin K antagonist oral anticoagulants vs Warfarin
Design
Review
Authors
Loading...
May support NOAC preference in Asian AF; leaves open need for dedicated RCTs to confirm.
Do NOACs improve stroke prevention and reduce bleeding compared to warfarin in Asian patients with atrial fibrillation?
NOACs are the preferred medication for stroke prevention in Asian patients with atrial fibrillation due to superior safety and efficacy profiles compared to warfarin.
Chiang et al. (2015) conducted a review in Atrial fibrillation. Non-vitamin K antagonist oral anticoagulants (NOACs) vs. Warfarin was evaluated on Stroke prevention. Non-vitamin K antagonist oral anticoagulants (NOACs) were superior or non-inferior to warfarin for stroke prevention in Asian patients with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: